Glucotrack announces proposed underwritten public offering of common stock

Rutherford, nj, april 12, 2023 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical device and digital health platform company focused on diabetes and prediabetes, today announced that it intends to offer shares of common stock in a firm commitment underwritten public offering. the company intends to use the net proceeds from this offering primarily for working capital and general corporate purposes, which may include, without limitation, engaging in acquisitions or other business combinations or investments, sales and marketing activities, general and administrative matters and capital expenditures.
GCTK Ratings Summary
GCTK Quant Ranking